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Summary  
Neuromuscular junctions are normally thought to comprise three major cell types: skeletal 
muscle fibres, motor neurone terminals and perisynaptic terminal Schwann cells. Here we 
studied a fourth population of junctional cells in mice and rats, revealed using a novel 
cytoskeletal antibody (2166). These cells lie outside the synaptic basal lamina but form caps over 
neuromuscular junctions during postnatal development. NMJ-capping cells also bound rPH, 
HM-24, CD34 antibodies and cholera toxin B-subunit. Bromodeoxyuridine incorporation 
indicated activation, proliferation and spread of NMJ-capping cells following denervation in 
adults, in advance of terminal Schwann cell sprouting. The NMJ-capping cell reaction coincided 
with expression of tenascin-C but was independent of this molecule since capping cells also 
dispersed after denervation in tenascin-C null mutant mice. NMJ-capping cells also dispersed 
after local paralysis with botulinum toxin and in atrophic muscles of transgenic R6/2 mice. We 
conclude that NMJ-capping cells (“kranocytes”) represent a neglected, canonical cellular 
constituent of neuromuscular junctions where they may play a permissive role in synaptic 
regeneration.  
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Introduction  
Neuromuscular junctions (NMJ) are interfaces between components of two main cell types: 
motor axon terminals and motor endplates of skeletal muscle fibres. In adult mammals and most 
other vertebrates, each motor endplate is normally innervated by a single motor axon terminal 
and in most muscle fibres this NMJ is constrained to less than 0.1% of the muscle fibre cell 
surface (Sanes & Lichtman, 1999; Beeson et al., 2006). The strength of synaptic transmission at 
each NMJ in a motor unit virtually guarantees that all the muscle fibres supplied by a motor 
neurone contract in response to every action potential conducted into its motor nerve terminals 
(Wood & Slater, 2001). NMJ’s are therefore crucial structures in the intercellular signalling 
processes that control movement and behaviour. Degeneration of motor nerve terminals occurs 
rapidly after motor axonal injury, axonal transport block or neuromuscular paralysis (Miledi & 
Slater, 1970; Brown et al., 1980; Hudson et al., 1984) and in early stages of motor neurone 
diseases such as amyotrophic lateral sclerosis (ALS; Fischer et al., 2004; Pun et al., 2006; David 
et al. 2007). Compensatory responses to such denervation include sprouting from intact 
neighbouring axons and regeneration of damaged axons (Brown & Ironton, 1978; Barry & 
Ribchester, 1996; Costanzo et al., 1999, 2000; Schaefer et al., 2005). Understanding the cellular 
organisation of NMJ’s and the mediators of their plasticity is therefore important: not only for 
the insights it provides into fundamental cell biology but also for identifying suitable cellular and 
molecular targets for effective treatment for ALS and other neuromuscular diseases.  
Motor neurones and muscle fibres are not the only cell types present at an NMJ. In the endplate 
region, myelinating Schwann cells ensheath intramuscular axon collaterals up to the last 
heminode of Ranvier, ensuring high-fidelity conduction of action potentials (Court et al., 2004). 
The nerve terminal itself is capped by non-myelinating terminal Schwann cells (tSC; Robertson, 
1956; Birks et al., 1960; Kang et al, 2003; Hayworth et al, 2006). These cells are contained in a 
continuation of the synaptic basal lamina and drape motor terminal branches and synaptic 
boutons, in register with other pre-and postsynaptic specialisations. Though not essential for the 
initial formation of neuromuscular synapses, tSC are required for maintenance of preterminal 
axon structure and function during development; for long-term maintenance of neuromuscular 
transmission in adult life; and they appear to play a path-finding role in compensatory sprouting 
responses following nerve injury and repair (Jahromi et al, 1992; Son & Thompson, 1995; 
Trachtenberg & Thompson, 1996; Castonguay and Robitaille, 2001; Reddy et al, 2003; Court et 
al., 2008). Thus, together, motor nerve terminals, muscle fibres and terminal Schwann Cells are 
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generally considered the three essential cellular elements that constitute the vertebrate 
neuromuscular junction (Sanes & Lichtman, 1999; Hughes et al., 2006).  
Here we report strong association of a fourth cell type with NMJ’s. This arose from a 
serendipitous initial finding: whole-mount immunofluorescent staining of skeletal muscle with a 
novel polyclonal antibody (2166) produced vivid cytoskeletal labelling of a sub-set of cells 
capping the NMJ but lying outside the synaptic basal lamina. These NMJ-capping cells may 
correspond to “endoneurial cells” first identified in the neighbourhood of NMJ’s in pioneering 
ultrastructural studies of the NMJ by Robertson (1956), or to cells of similar appearance referred 
to by Weis et al. (1991) as “perisynaptic fibroblasts”. However, the data here suggest a much 
tighter association of NMJ-capping cells than that indicated by these previous studies. NMJ–
capping cells become restricted to neuromuscular junctions during postnatal development but 
within 24 hours of denervation or paralysis in adults, they proliferate and spread throughout the 
perijunctional region, ahead of reactive sprouting of either terminal Schwann cells or 
regenerating motor axons. Taken together, these findings suggest that mammalian 
neuromuscular junctions comprise four cell types, not three, and that NMJ–capping cells should 
be considered as integral constituents of neuromuscular junctions.  
Results  
2166-antibody stains NMJ-capping cells  
Antibody 2166 was raised in rabbits against an epitope of Tspan-2, an oligodendrocytespecific 
tetraspanin protein of 25kDa (Birling et al, 1999; Terada et al, 2002). The original intention was 
to use this antibody to map oligodendrocyte disposition and lineage in the brain. However, 
preliminary analysis using western blots suggested the antibody recognised a protein of 47kDa, 
which was not Tspan-2 (see Methods). Immunostained sections of brain indicated the antibody 
did not stain oligodendrocytes either. Since the potential utility of the 2166 antibody did not 
depend on knowledge of its primary antigen we proceeded to test it for potential binding to other 
neural tissues, including neuromuscular junctions, mainly anticipating the possibility of 
peripheral myelin or terminal Schwann cell staining.  
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Remarkably, 2166-immunostaining of whole-mount preparations of the mouse triangularis sterni 
(TS) muscle revealed a sub-population of cells, some of which were localised to neuromuscular 
junctions, where they formed caps over the motor nerve terminals. The 2166 antibody evidently 
stained the cytoskeleton in these capping cells (Fig. 1A-C; and see below) and frequently took 
the form of a lasso around the cell nucleus, appearing to extend into numerous filopodial or 
lamellipodal cellular processes. In most cases these extended over and beyond the boundaries of 
the motor endplate, as indicated by binding of rhodamine-conjugated α-Bungarotoxin (TRITC-α-
BTX), a specific ligand for postsynaptic AChR. We subsequently observed 2166-positive cells 
capping neuromuscular junctions in several other skeletal muscles in mice and rats (diaphragm, 
soleus, EDL, FDB, and DL). Thus, we refer to the NMJ-localized 2166positive cells throughout 
the Results section of this report as “NMJ-capping cells” (see Discussion, for justification of a 
proposed alternative name: “kranocytes”).  
Although the disposition of NMJ-capping cells was unequivocal, several other forms of 2166-
immunopositve cells were observed beyond the junctional region in confocal micrographs, 
including the optical sections above and below the NMJ’s. However, there was only enrichment 
of 2166-positive cells in the vicinity of intramuscular nerves and in contrast to the morphology 
of NMJ-capping cells, virtually all of the 2166-positive extrajunctional cells had a bipolar form, 
with extensions running along the longitudinal axis of the muscle fibres (Fig. 1D). 2166-positive 
cells showing a similar bipolar form were also associated with intramuscular capillaries (Fig. 
1E).  
 
The only clusters of capping-cells were found around motor endplates. We counted the number 
of 2166-positive cells at neuromuscular junctions in adult TS muscles, counterstained with the 
nuclear marker DAPI (n=5 muscles, 100 neuromuscular junctions analysed). All neuromuscular 
junctions were capped by at least one 2166-positive cell. About 25% exhibited two, with fewer 
than 10% showing three (Fig. 1F). Outside the region of the NMJ’s, 2166-positive cells did not 
show any discernible clustering.  
 
NMJ-capping cells show a distinct immunocytochemical profile  
Immunocytochemical analysis (Table 1) clearly resolved NMJ-capping cells from terminal 
Schwann cells and suggested a distinct identity. First, double immunostaining with 2166 
antibody and antibodies for either GFAP or nestin showed no co-localisation, demonstrating that 
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NMJ-capping cells are not terminal Schwann cells. We confirmed this by 2166 immunostaining 
in S100-eGFP mice (Zuo et al, 2004) in which all myelinating and terminal Schwann cells are 
endogenously fluorescent (Fig. 2A). The 2166 immunostaining pattern was completely different 
and extended beyond the boundaries of the Schwann cell plasma membrane. Immunostaining for 
M-cadherin, NCAM or desmin also did not label NMJ-capping cells, suggesting that they were 
not muscle satellite cells (Sanes et al, 1986; Fukada et al, 2004). Finally, absence of F4/80 
immunostaining appears to rule out any identity with macrophages (Austyn & Gordon, 1981).  
We next examined whether NMJ-capping cells might be a specialised form of fibroblast. The 
exact disposition of “perisynaptic fibroblasts” is unclear from previous reports, since they were 
depicted diagrammatically as near to, but not overlaying, neuromuscular junctions (Murray & 
Robbins, 1982; Gatchalian et al, 1989; Weis et al, 1991). No discernible immunofluorescence of 
NMJ-capping cells was detected using Thy-1 antibody, although axons, which also express Thy-
1 antigen were immunolabeled (Reynolds & Woolf, 1992; Feng et al, 2000; Van der Putten et al, 
2000). There were other Thy-1 positive cells near the NMJ but these did not include the 2166-
positive NMJ-capping cells (Supplementary Fig. 1A). These positive controls confirmed the 
antibody’s specificity and affinity. Thus, 2166 cells may not correspond to the Thy-1 positive 
perisynaptic fibroblasts previously reported.  
 
As a further test, we immunostained rat TS muscles using a mouse antibody against the rat 
isoform of prolyl-4-hydroxylase (rPH), an enzyme regulating the synthesis of collagen (Aiba et 
al,1994; Smith et al, 1998). Positive staining for rPH was localised to 2166positive cells above 
the NMJ although it did not overlap with 2166 immunostaining (Fig. 2B). Scrolling through 
individual optical slices (Z-series; see for example Supplementary Movies 1 and 2) showed rPH 
and 2166 staining were in the same cells. Thus, rPH is an enzyme evidently located in an 
intracellular compartment, possibly the endoplasmic reticulum (Nissi et al., 2001), near to but 
not overlapping the cytoskeletal components stained by 2166 antibody. Since 2166 antibody 
appeared to label specific cytoskeletal components, it is not surprising that it failed to colocalise 
with rPH. We did not examine whether rPH-positive fibroblasts in other tissues are also 2166-
positive but it seemed clear that at least some cells with fibroblast-like characteristics also 
express the 2166 antigen.  
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The pattern of labelling of NMJ-capping cells suggests that the 2166 antigen is spatially quite 
restricted: for instance, there were substantial parts of the cells -mostly near the periphery -where 
there was no 2166 labelling. To test whether the 2166 staining colocalises with other components 
of the cytoskeleton, we co-immunostained NMJ-capping cells with actin, vimentin or tubulin. 
The 2166 immunostaining was more restricted, with no strong co-localisation with these other 
cytoskeletal markers (data not shown).  
Next, while searching cytological literature for evidence of NMJ-capping cell disposition, we 
noted the strong resemblance of 2166 antibody staining of the NMJ-capping cells to staining for 
neuregulin (GGF II) at NMJ, reported by Trinidad et al (2000). These authors used the HM-24 
antibody and attributed the staining pattern to terminal Schwann cells. However, in our hands, 
HM-24 positive staining was not observed in S100-eGFP positive terminal Schwann cells (Fig. 
2B). It was not possible to double-stain NMJ-capping cells with 2166 and HM-24 antibodies 
because both were raised in rabbits but the HM-24 immunostaining pattern extended beyond the 
boundaries of the tSC’s. Interestingly, the pattern of HM-24 staining also appeared similar to the 
cytoskeletal labelling pattern of the 2166 antibody (see also Figure 4D3 in Trinidad et al., 2000), 
which is perhaps surprising for neuregulin distribution. It is puzzling that Trinidad et al did not 
report seeing HM-24 staining in cells lying outside the synaptic basal lamina (see below). 
However, the present data suggest that junctional HM-24 positive cells appear to be identical to 
the NMJ-capping cells that we identified using the 2166 antibody.  
Next, we looked for possible cell-surface markers of NMJ-capping cells. A stem cell population 
located in interstitial spaces of skeletal muscle, outside the basal lamina, has been identified 
previously and isolated by immunostaining for the hematopoietic stem cell marker CD34 
(Torrente et al, 2001;Tamaki et al, 2002). We found that the surfaces of NMJ-capping cells 
showed uniform, faint immunostaining for CD34 (Fig. 3A,B). These preparations revealed 
additional aspects to the disposition of NMJ-capping cells: they frequently covered and extended 
beyond the NMJ and contacted the muscle fibre outside the end-plate perimeter, sometimes 
extending processes between adjacent motor endplates (Fig. 3B). This analysis also confirmed 
that the 2166 antigen was contained within the cytoskeletal framework of CD34-positive NMJ-
capping cells. Orthogonal projections of the NMJ-capping cell showed that they were separated 
from the muscle fibre surface by about 3 µm and therefore that they were located outside the 
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synaptic basal lamina (Fig. 3B; Supplementary Figure 2). We confirmed this in transverse 
muscle sections co-immunostained with anti-laminin and 2166 antibodies, together with TRITC-
α-BTX staining of ACh receptors (Fig. 3C).  
Finally, we found that fluorescent conjugates of cholera toxin B-subunit (CTB) highlighted the 
plasma membranes of NMJ-capping cells (Fig. 3D). We chose this reagent because it binds to 
GM1 gangliosides, which are absent from terminal Schwann cells (Halstead et al., 2005). Like 
CD34 staining, membrane staining with CTB extended beyond the cytoskeletal staining with 
2166 and also revealed several instances of fine cellular processes extending between motor 
endplates (Supplementary Movies 3,4, and 5). We did not attempt double-labelling with CD34 
antibody and CTB but they otherwise appeared to have similar distributions.  
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Ultrastructural disposition of NMJ-capping cells  
We noted that many electron micrographs of NMJ’s in textbooks (e.g. Peters et al., 1991) crop 
images of NMJ’s to exclude cells other than tSC’s, nerve terminals and muscle fibres. However, 
original published transmission electron micrographs of NMJ’s in frogs, lizards, chickens, mice, 
rats and humans frequently show slender cellular processes overlying the other principal cell 
types of the NMJ (Robertson, 1956; Desaki & Uehara, 1981; Connor & McMahan, 1987; Slater 
et al, 1992; Connor, 1997; see also Fig.4D). Thus, to extend the confocal microscopy data above 
we made electron micrographs from 300 ultrathin (75-100nm) serial-sections of one randomly-
selected NMJ in a mouse TS muscle. We highlighted the profiles of the muscle fibre, motor 
nerve terminal, terminal Schwann cells and two putative NMJ-capping cells identified at this 
NMJ (Fig. 4A,B).  
Volume-rendering of a three-dimensional reconstruction of all of these cellular components 
confirmed the shape and relationship of the NMJ-capping cells with the other cellular 
components of the NMJ, as observed using light microscopy (Fig. 4C; Supplementary movies 6 
and 7). For instance, the EM reconstruction confirmed the impression from confocal microscopy, 
indicating that the cellular processes of NMJ-capping cells are quite laminar.  
Confocal microscopy suggested that NMJ-capping cells themselves lack a basal lamina (see Fig 
3C). However, micrographs like that shown in Fig. 4D indicate that capping cells are tightly 
ensheathed by a thin layer of extracellular matrix (See also Supplementary Figure 3). Previous 
studies suggest that perisynaptic fibroblasts are also rich in endoplasmic reticulum. This appears 
also to be the case, at least for the capping cell shown in Fig. 4D/Supplementary Figure 3.  
In summary, whether NMJ-capping cells are identical to “perisynaptic fibroblasts” described 
previously by others remains open. The data reported above rather suggests that NMJ-capping 
cells represent a distinct sub-population of cells, defined by their shape, strong association with 
neuromuscular junctions, and a distinctive molecular profile as indicated by staining with a 
unique combination of five cytological markers: antibodies 2166, rPH, HM-24, CD34, and with 
CTB.  
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Development and Plasticity of NMJ-capping cells  
The remarkable localisation of NMJ-capping cells, revealed here both by light microscopy of 
whole-mounts and by their reconstruction from electron micrographs, naturally led us to enquire 
about their possible functions. We focused initially on the patterns of 2166-immunostaining 
during early postnatal development and then we studied the effects of muscle atrophy, induced 
either by denervation, paralysis or disease. Finally, we investigated an association with tenascin-
C, an early molecular marker of denervation, seeking insight into the possible mechanism of 
NMJ-capping cell plasticity.  
2166-positive cells become restricted to NMJ postnatally  
We immunostained TS muscles of postnatal mice aged 1-28 days (P1-P28). Neuromuscular 
junctions in these preparations were co-stained using neurofilament antibodies and fluorescent 
TRITC-α-BTX. At P1, 2166-positive cells were homogenously distributed along the TS muscle 
with no clear pattern of localisation to NMJ’s (Fig. 5A). Between P5 and P10, 2166-positive 
cells became more restricted to endplate bands adjacent to intramuscular nerve branches but the 
degree of refinement between these times was not compelling (Fig. 5B-C). The pattern changed 
dramatically after P10 and by P28 2166-positive cells were highly restricted to the 
neuromuscular junctions, as shown in Figures 1-3.  
2166-positive cells spread after denervation, paralysis or muscle atrophy  
Next, we partially denervated TS muscles in adult mice, then immunostained them 1-6 days later 
with nestin antibody, a marker of reactive terminal Schwann cells (Hayworth et al, 2006; Kang et 
al., 2007). As expected, at innervated neuromuscular junctions nestin was expressed only in 
muscle fibres; terminal Schwann cells remained nestin-negative for at least 2 days after 
denervation (Fig. 5D). However, the images suggest that profusion of 2166-positive cells was 
evident in the denervated endplate regions of TS muscles within one day of intercostal nerve 
injury; and many of these cells appeared to have grown processes interconnecting NMJ’s (Fig. 
5E, Supplementary Figures 1 & 4). This response was local to denervated endplates: innervated 
NMJ’s in the same partiallydenervated muscles were covered by NMJ-capping cells confined to 
the AChR cluster region, as in unoperated muscles. Some of the reactive, nestin-positive 
Schwann cell processes that formed 1-3 days later evidently became associated with the 2166-
positive cell processes interconnecting motor endplates (Fig. 5F, Supplementary Fig. 5; 41 
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junctions observed with this association in 4 muscles). We were unable to apply 
immunocytochemistry to study the relationship between S100-positive Schwann cells and 2166-
positive NMJ capping cells in mice, because both the 2166 antibody and commercial S100 
antibody were raised in rabbits (hence unresolvable with anti-rabbit secondary antibodies). 
However, reactive Schwann cells in a partially denervated rat 4
th 
deep lumbrical muscle stained 
using a mouse S100 antibody showed Schwann cell sprouts aligned with inter-endplate processes 
from 2166-positive NMJ-capping cells (Supplementary Fig. 1B, Supplementary Figure 4).  
The above findings suggested two hypotheses: first, that NMJ-capping cells selectively 
proliferate after nerve injury and second, that these cells play an instructive role in sprouting by 
first activating terminal Schwann cells and then guiding their sprouts to denervated endplates. 
The data below support the first hypothesis but not the second, suggesting that the NMJ-capping 
cell response to denervation, paralysis or muscle atrophy probably occurs independently of the 
terminal Schwann cell reaction.  
To test the first hypothesis we denervated TS muscles of seven adult mice and injected them 
with bromodeoxyuridine (BrdU) either 1 day (three mice) or 3 days (four mice) later. 
Incorporation of BrdU by NMJ-capping cells was assessed by immunofluorescence. Nuclei of 
NMJ-capping cells were distinguished from others (muscle and Schwann cell nuclei) by the 
characteristic 2166 staining forming lasso-like structures around the nuclei (see also Fig. 1, for 
example). We expected that the BrdU pulse would only mark cells within the first hour of 
injection, thus labelling only a small fraction of the 2166-positive cells that may have 
proliferated. We were therefore not surprised by the apparent absence of BrdU labelling at 1d; 
and by three days, only about 7% of all 2166-positive cells were BrdU positive. However, more 
than 65% of these cells were located within 40 µm of the neuromuscular junctions (Fig. 5G). 
These observations suggest that NMJ-capping cells were stimulated to spread then divide as an 
early consequence of endplate denervation. However, from these data we cannot exclude the 
possibility that the 2166-positive cells in the denervated endplate region may become 
supplemented by invasion of reactive cells from outside the endplate zone as well.  
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To resolve whether the spread and proliferation of NMJ-capping cells could constitute an 
instructive signal that triggers the Schwann cell reaction to denervation (Son et al, 1996), we 
took advantage of the slow response of Schwann cells and axons in the TS muscle to 
neuromuscular paralysis (unpublished observations), similar to that reported for “fasyn” types of 
muscle by Pun et al (2002). We injected botulinum toxin type A (BoNT/A) into the interstitial 
spaces between the TS and intercostal muscles. The animals were sacrificed 1-6 days later. 
Stimulation of the intercostal nerves supplying the isolated muscles gave no contractile 
responses, confirming the neuromuscular block, whereas stimulation of saline-injected control 
muscles produced vigorous muscle contractions.  
The responses of NMJ-capping cells and tSC in BoNT/A-injected muscles were quite different 
from those in denervated muscle. After only one day of muscle paralysis the profusion of 2166-
positive cells in the junctional region was not discernibly different from that induced by 
denervation. However, tSC remained nestin-negative and failed to show discernible evidence of 
sprouting for at least 6 days (Fig. 6A-B). The 2166-positive cells were clearly dispersed over and 
between neuromuscular junctions, as in denervated muscle (compare with Fig. 5). Since the 
Schwann cell and NMJ-capping cell reactions were dissociated in time by BoNT/A paralysis, we 
conclude that the role of NMJ-capping cells in adaptive responses to nerve injury may be to lay 
down a substrate that could be conducive to reactive Schwann cell outgrowth, but this does not 
necessarily trigger or instruct tSC’s to react. These cells evidently respond to cues arising from 
denervated or paralysed muscles independently of those that trigger earlier reaction of NMJ-
capping cells.  
 
Since denervation and paralysis had distinct temporal effects on terminal Schwann cells in TS 
muscles but both were sufficient to induce NMJ-capping cell proliferation and spread, we next 
asked whether inactivity was strictly necessary for this reaction or whether some other, intrinsic 
signal from muscle fibres was sufficient. To test this we examined NMJ-capping cells in TS 
muscles of R6/2 transgenic mice (normally used to model Huntington’s disease; Mangiarini et al, 
1996). These mice develop profound, constitutive muscle atrophy and show several other 
characteristics of denervated muscle even though their muscle fibres are fully innervated and 
they show no physiological evidence of paralysis. In fact, there are very few discernible 
abnormalities in the morphology of either Schwann cells or motor nerve terminals at most 
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(>95%) of the NMJ’s in these mice (Ribchester et al 2004). Muscle atrophy in R6/2 mice is 
therefore likely to be either myogenic or to have some other non-neural explanation. Moreover, 
Schwann cells and axons retain their capacity to sprout when muscles in R6/2 mice are surgically 
denervated, as in normal mice (Ribchester et al 2004). We therefore used 2166 antibody to 
immunostain TS muscles dissected from two 15-week old R6/2 mice, towards the endstage of 
disease. As expected (Carter et al, 1999) both of these mice showed decreased body weight and 
showed significant muscle atrophy. If denervation or paralysis were necessary for the NMJ-
capping cell reaction, we should have expected to see no differences in their distribution in R6/2 
mouse muscles compared with wild-type mice, in spite of their muscle atrophy.  
Surprisingly, the appearance and disposition of 2166-positive cells in R6/2 mice were similar to 
those observed following either denervation or paralysis of wild-type muscle (Fig. 6C,D). These 
observations support the interpretation that activation of NMJ-capping cells does not inevitably 
or invariably lead to activation of Schwann cells. The data also suggest that denervation and 
paralysis, though sufficient (see above), are not necessary for the induction of the NMJ-capping 
proliferation and spread. Thus, taken together, the NMJ-capping cell reaction that evidently 
occurred in all three circumstances – denervation, paralysis and atrophy (without paralysis) – 
suggests that factors triggering or triggered by atrophy of muscle fibres are responsible for their 
reactivity, rather than factors associated directly with reactive terminal Schwann cells.  
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What molecules cue the NMJ-capping cell reaction?  
Previous data suggest that reactive perisynaptic fibroblasts express several adhesion molecules 
including tenascin, NCAM, fibronectin and heparan sufate proteoglycan and that perisynaptic 
fibroblasts may be one source of tenascin (Covault & Sanes, 1985; Sanes et al, 1986; Gatchalian 
et al, 1989; Weis et al, 1991). These molecules have also been implicated in nerve sprouting and 
regeneration (Cifuentes-Diaz et al, 1998). Confirming this, we observed no positive 
immunostaining for tenascin-C in innervated neuromuscular synapses of wild-type mice but 
strong immunostaining for this molecule at neuromuscular junctions denervated for three days 
(Fig. 7A,B). After 6 days, tenascin-C expression had also spread from the neuromuscular 
perimeter and 2166-positive cells lay in register with these tenascin-C immunopositive regions 
(Fig. 7C).  
Next, we examined the pattern of tenascin-C immunostaining following TS muscle denervation 
in tenascin-C null mutant mice. We carried out X-gal staining of denervated muscles in a group 
of heterozygous tenascin-C null-mutant mice in which the deleted sequence was substituted with 
a lac-Z reporter gene (Saga et al, 1992; Garcion et al, 2004). As expected, we found no positive 
lac-Z positive staining in innervated regions of TS muscles from these mice. However, 5 days 
after nerve section there was strong positive staining of the intramuscular axon and motor 
endplate region only: areas expected of Schwann cells or endoneurial or perineurial fibroblasts, 
and also consistent with tenascin-C expression by NMJ-capping cells (Fig. 7D,E). However, 
there was no compelling evidence that other 2166-positive cells expressed tenascin-C (compare 
Fig. 7C with 7D,E). Finally, we immunostained TS muscles with 2166 antibody in four 
homozygous tenascin-C null-mutant mice before and after intercostal nerve section. In 
unoperated muscles, NMJ-capping cellular localisation was indistinguishable from wild-type 
controls, suggesting that tenascin-C is not necessary for accumulation of these cells to NMJ’s 
during postnatal development (compare Fig. 7F with Fig. 1A-D and Fig. 5E,F). There was no 
discernible difference in the NMJ-capping reaction within the first 48 hours of denervation either 
(Fig. 7G).  
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We therefore conclude that expression of tenascin-C, although normally associated with the 
spread of NMJ-capping cells following denervation, is neither required for the initial localisation 
of NMJ-capping cells to endplates during development, nor for their proliferation and spread 
following nerve injury. Presumably, other molecules – or combinations of molecules – mediate 
the NMJ-capping cell reaction.  
Discussion  
The results suggest that mammalian NMJ’s normally comprise four cell types: these canonical 
constituents being muscle fibre, motor neurone, terminal Schwann cell and the NMJ-capping 
cell: a neglected cell-type that merits further investigation as a potential moderator of 
neuromuscular synaptic development, maintenance and plasticity. Evidence for this may be 
summarised as follows; then we discuss in more detail the identity of NMJ-capping cells; their 
possible significance of their immunocytochemical profile; and their development and plasticity.  
First, serendipitously, we found that antibody 2166 immunostains a distinct population of cells 
capping NMJ’s, lying outside the synaptic basal lamina but co-localised with terminal Schwann 
cells, motor nerve terminals and muscle fibres at motor endplates. Confocal microscopy of whole 
mounts immunostained with the 2166 antibody and other markers were pivotal in demonstrating 
the consistent presence and association of NMJ-capping cells with motor endplates. It is perhaps 
important to note that estimates of the numbers of tSC’s at motor endplates should therefore take 
into account the evidence that most NMJ also localize 1-2 kranocytes (see data in Figure 1).  
Second, NMJ-capping cells become restricted to the endplate region during postnatal 
development but react to either denervation or paralysis in adults by proliferation and spread 
from endplates. This occurs more rapidly than the reactive response of terminal Schwann cells. 
NMJ-capping cells also take the lead in forming bridges (or consolidating existing ones; see 
Figure 3) between neuromuscular junctions following muscle denervation or paralysis, ahead of 
terminal Schwann cells. This novel finding may be significant for understanding mechanisms of 
compensatory nerve sprouting and regeneration. NMJ-capping cells are also dispersed from NMJ 
in a disease model (R6/2 transgenic mice), where there is muscle atrophy but no paralysis or 
denervation. Since the structure and function of motor nerve terminals and terminal Schwann 
cells appear largely normal in these mice, a parsimonious explanation is that the signalling 
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mechanism that induces the proliferation and spread of NMJ-capping cells derives from 
denervated, paralysed or atrophic muscle fibres rather than any other cell type at NMJ.  
Third, while the above suggest that one of the functions of NMJ-capping cells may be in repair 
of damaged neuromuscular connections, the data also suggest that the NMJ-capping cell reaction 
does not require or depend on tenascin-C, one of the early molecular markers previously 
associated with axonal sprouting and regeneration.  
The identity of NMJ-capping cells  
The present data underscore the importance of a pioneering ultrastructural study by Robertson 
(1956) who identified “endothelial” cells associated with the NMJ (see Text Fig 1 in Robertson, 
1956). The consistency of this association and the potential role of these cells in maintenance of 
the normal structure and function of the NMJ has been somewhat neglected since. However, 
similar non-neural cells were identified in scanning electron micrographs by Desaki & Uehara 
(1981), who described them as “flattened stellate cells of unknown nature”. Other investigators 
recognised the association of fibroblast-like cells to NMJ, including Murray & Robbins (1982), 
McMahan and colleagues (Connor & McMahan, 1987; Connor, 1997), Caroni & Schneider 
(1994); and Sanes and colleagues, in their description of “perisynaptic fibroblasts” (Covault & 
Sanes, 1985; Sanes et al,1986; Connor & McMahan, 1987; Connor, 1997; Gatchalian et al, 1989; 
Weis et al, 1991). Perhaps perisynaptic fibroblasts and NMJ-capping cells are the same (and 
have identity with the endothelial cells of Robertson, 1956) but this remains unproven. 
Nevertheless, the parallels are striking: like “perisynaptic fibroblasts” the capping cells 
proliferate in response to denervation; they are fibroblast-like; and they appear to change their 
gene expression in response to nerve injury. It is therefore rather surprising that reviewers have 
been reluctant to depict these cell types as essential components of the NMJ (Sanes & Lichtman, 
1999; Hughes et al, 2006).  
 
Taking the present and previous observations together, we suggest that the NMJ-capping cells 
ought now to be considered an integral cellular component of neuromuscular junctions and 
therefore represented as such in diagrammatic depictions of the neuromuscular junction (e.g. Fig. 
8A). At this time we suggest naming these capping cells descriptively, as neuromuscular 
“kranocytes” (from Greek, κρανος , meaning helmet), which acknowledges their main 
J Cell Sci. 2008 Dec 1;121(Pt 23):3901‐11. doi: 10.1242/jcs.031047. Epub 2008 Nov 11. 
 
morphological characteristics. We use this nomenclature for the remainder of the present 
discussion.  
 
Immunocytochemical profile of kranocytes  
We screened kranocytes using a panel of antibodies, including those previously associated with 
different cell types in skeletal muscle. Of the antibodies tested, HM-24, prolyl-4-hydroxylase 
(rPH) and CD34 gave positive staining. Kranocytes also bound fluorescent cholera toxin B-
fragment (CTB). The CD34 and CTB labels suggest a more complete covering of the NMJ by 
the capping cells than 2166 (or HM-24) staining. The explanation appears to be that 2166 stains 
the non-uniform distribution of a cytoskeletal protein whereas CD34 antibody and CTB label the 
plasma membranes of these cells.  
Staining with HM-24 antibody revealed an intriguing contrast to a previous study of the 
localisation of the antigen to NMJ’s. Trinidad et al (2000) reported HM-24 (ie neuregulin) 
immunoreactivity to be within terminal Schwann cells. However, our observations based on 
immunostaining in S100-GFP expressing transgenics (see Figure 2), suggest that kranocytes are 
HM-24 positive but tSC are not. The methods we used differ, principally in our use of 
triangularis sterni muscle whole-mounts rather than tissue sections. But since Trinidad et al 
(2000) did not consider or rule out the possibility that HM-24 antibody might have 
immunostained a fourth cell type, we suggest their conclusion may have been mistaken. The 
localization of neuregulin (or a neuregulin-like molecule) to kranocytes rather than tSC could 
have important implications for understanding the development and maintenance of 
neuromuscular junctions so it will be important to fully resolve this issue.  
 
The enzyme rPH is involved in the synthesis of collagen (Pihlajaniemi et al, 1991) but cell types 
other than fibroblasts, including endothelial cells and myelin-forming Schwann cells, also 
express rPH (Singh et al, 1997; Vanderwinden et al 1999). Kranocytes were also 
immunopositive for CD34 antigen, previously identified as an endothelial or hematopoietic stem 
cell marker (Krause et al, 1994). CD34-positive/rPH-positive haematopoietic stem cells may 
give rise to fibroblasts (Lee et al, 2000; Zulli et al., 2005). It might therefore be interesting to 
investigate further the pluripotential (ie stem-cell) capacity of neuromuscular kranocytes, 
especially in light of a recent report that fibroblasts may be reprogrammed into a fully 
pluripotential state following ectopic expression (via retroviral vectors) of the transcription 
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factors Oct-4, Sox-2, c-Myc and Klf4 (Wernig et al., 2007; Takahashi et al., 2007).  
The surface expression of the CTB receptor (a GM1 ganglioside) suggests another way that more 
information might be obtained about the normal functions of these cells. For instance, ablation of 
terminal Schwann cell at the neuromuscular junction can provide information about their short 
and long term functions in sustaining motor nerve terminals (Reddy et al, 2003; Halstead et al, 
2004, 2005). In preliminary experiments we found that antiganglioside antibody DG2 ablates 
motor nerve terminals, terminal Schwann cell and NMJ-capping cells by complement-mediated 
cell lysis (unpublished observations). If a more selective ablation of kranocytes becomes 
possible, it will be interesting to examine the long-term effects of this on neuromuscular 
development, maintenance and repair.  
Developmental and plasticity of kranocytes  
2166-positive cells become restricted to the neuromuscular contact zone during postnatal 
development. Similar developmental restriction of non-neural cells to NMJ’s was reported in 
frogs (Connor, 1997). Whether this is due to changes in the composition of the basal lamina at 
the neuromuscular junction (Patton et al, 1997; Sanes et al, 1990; Cho et al, 1998) or other 
phenomena at endplates, such as endogenous electric fields ((Betz et al, 1980b; Kinnamon et al, 
1985) remains to be established. Abnormalities of synaptic structure have been demonstrated in 
mutant mice that lack specific components of the synaptic basal lamina (Noakes et al, 1995; 
VanSaun et al, 2003). It will be interesting to examine the disposition of kranocytes in mutant 
mice lacking specific basal lamina components (or endogenous electric fields; etc.).  
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A role for kranocytes in neuromuscular plasticity is suggested by their reaction in adults to nerve 
injury or paralysis. This reaction occurred at least two days earlier than the reactive 
transformation of terminal Schwann cells. This early reaction does not detract from the pivotal 
role played by reactive tSc in leading regenerating axons to denervated or paralysed motor 
endplates (Son et al, 1996; Love & Thompson, 1998, 1999; Love et al., 2003; Kang et al, 2003). 
Rather, the data underscore the importance of tSC’s, by demonstrating that their transformation 
to a reactive state is not an inevitable consequence of early reaction and spread of kranocytes. 
Perhaps kranocytes consolidate the cellular bridges they appear to form between motor endplates 
and these are subsequently utilized by reactive tSc’s. Terminal Schwann cell bridges then 
support subsequent axonal sprouting and regeneration (Fig. 8B). It is noteworthy that electrical 
stimulation of denervated rat muscle does not prevent Schwann cells from becoming reactive, 
but it strongly inhibits the formation of Schwann cell bridges between endplates (Love et al, 
2003). It would be interesting to know whether stimulation also prevents the reaction of 
neuromuscular kranocytes to denervation.  
We also found evidence of dispersal of the population of 2166-positive cells in atrophic muscles 
of the R6/2 transgenic mouse model of Huntington’s disease. However, since motor nerve 
terminals, terminal Schwann cells and neuromuscular transmission appear largely normal in 
R6/2 mice (Ribchester et al, 2004), denervation, paralysis or muscle atrophy would appear to be 
sufficient to provoke the kranocyte cell reaction; but the reaction of these cells is evidently not 
sufficient to trigger the subsequent Schwann cell reaction in this disease model. It would be 
interesting to know the disposition and fate of kranocytes in other models of neuromuscular 
disease, particularly models of amyotrophic lateral sclerosis, where neuromuscular synaptic 
degeneration is among the earliest signs of disease (Fischer et al., 2004; Schaefer et al., 2005; 
Pun et al., 2006; Suzuki et al., 2007).  
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Conclusions  
The focal distribution of a specific sub-population of antibody 2166-positive cells to 
neuromuscular junctions together with their progressive restriction to these areas during 
postnatal development and their persistence at synapses following muscle denervation, paralysis 
or atrophy, suggest important roles for kranocytes in the development, neurotrophic maintenance 
and repair of neuromuscular junctions. Several important questions remain:the possible 
gliotrophic function of kranocytes; the mechanism of their restriction to motor endplates, the 
functions of this developmental restriction; the significance of their proliferation and spread in 
atrophic muscle; and, finally, the identity of the 2166-antigen that was crucial in identifying 
these cells. Since we now have very good markers for kranocytes, there is a much greater 
potential than in the past for obtaining more information about the functions of these intriguing 
cells. Harnessing the molecular secretions of these plastic cells could perhaps also be utilised in 
targeting potential neuroprotective factors to neuromuscular junctions, potentially mitigating or 
preventing early signs of neuromuscular disease.  
Materials and Methods  
Generation of 2166 antibody  
The 2166 antibody was generated from a peptide (amino acid sequence CAIRNSRDVI) 
corresponding to the C-terminus of the Tspan-2 protein, coupled to keyhole limpet hemocyanin 
(KLH). This peptide was used to inoculate male New Zealand white rabbits of approximately 1.5 
Kg in weight. After three injections of KLH-coupled peptide, serum was collected at appropriate 
time points and affinity purified. We made a preliminary attempt to identify the putative antigen 
by western blotting of a cytoskeletal protein fraction from cerebellum (data not shown). The 
antibody recognised a band of approximately 47 KDa. Analysis by mass spectrometry was 
consistent with an antigen of similar molecular weight to tubulin. Pre-immune serum was 
inactive and specific staining was blocked by preincubating the active serum with the peptide 
used to raise the antibody. However, we were unable to achieve immunoprecipitation of any 
specific protein with the 2166 antibody and it did not recognise purified tubulin on western blots.  
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A more stringent fractionation and/or proteomic analysis may therefore be necessary to identify 
the 2166 antigen.  
Animals and surgery  
All animals were maintained in a regulated, clean environment and treated in compliance with 
UK Home Office regulations. Adult female Sprague-Dawley rats were used in some experiments 
but most experiments were performed using the following mouse lines: C57Bl/6, S100-eGFP 
transgenic (accessed during a visit by one of us (FAC) to Prof P Caroni’s laboratory), R6/2 
transgenic (Ribchester et al., 2004) and tenascin-C null mutant (TNC/TN-F18; Saga et al, 1992; 
donated by Prof C ffrench-Constant). Tenascin-C null mutant mice were genotyped as described 
by Garcion et al (2004). In some experiments, adult mice were anaesthetised intraperitoneally 
with 1mg/kg medetomidine (Domitor), 75mg/kg ketamine (Vetalar) and one or more of the 
intercostal nerves supplying the triangularis sterni (TS) muscle were crushed unilaterally. In 
other anaesthetised adult mice, intercostal muscles adjacent to the TS muscle were injected with 
2.5 µl botulinum toxin type A (BoNT/A;10 ng/ml; Sigma) from a Hamilton syringe. Surgically-
prepared animals were recovered for 1-6 days. All animals were sacrificed by cervical 
dislocation.  
Immunocytochemistry and histochemistry  
Whole-mount preparations were made by dissecting TS muscles in 0.1 M phosphate buffered 
saline (PBS, pH 7.4), fixed in 4% paraformaldehyde for 20 minutes, then incubated in either 
TRITC-or Alexafluor-647 conjugates of α-bungarotoxin (Molecular Probes; 5 µg/ml for 30 min). 
After washing in PBS and blocking/permeabilisation for one hour in 1% BSA, 0.4% Lysine, 
0.5% Triton X-100 in PBS, primary antibodies (see below) were applied overnight at 4 
0
C. 
Muscles were washed and incubated with secondary antibodies for 3.5 hours at room 
temperature, washed and mounted in Vectashield (Vector Labs). Most of the observations 
reported in the Results were based on analysis of four whole-mount preparations per 
immunostain combination. For muscle section immunocytochemistry, dissected muscles were 
embedded in OCT (Tissue TEK) and frozen in isopentane precooled with liquid nitrogen. 
Cryostat sections were collected, fixed with 4% paraformaldehyde for 5 minutes, then blocked 
and permeabilised for 1 hour with 5% fish gelatine and 0.1% Triton X-100 in PBS. Primary 
antibodies (see below) were applied overnight at room temperature. Sections were washed and 
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incubated with secondary antibodies for 1 hour at room temperature, washed in PBS and 
mounted in Vectashield. Preparations were imaged using a BioRad Radiance 2000 confocal 
microscope on a Nikon Eclipse E600-FN platform. For staining with cholera toxin B (CTB), TS 
muscles from male Balb/c mice (6-8 weeks) were dissected, pinned on Sylgard-lined dishes and 
bathed in FITC-conjugated CTB (Sigma, 1:300) and a Texas-Red conjugate of α-bungarotoxin 
(Molecular Probes, Eugene), diluted 1:500 in oxygenated saline for 2 hours at 32 °C, followed 
by 30 min at 4°C, rinsed in buffer, fixed at room temperature for 15 minutes in 4% 
paraformaldehyde, rinsed in 0.1M glycine and mounted in Citifluor anti-fade reagent (Citifluor, 
Canterbury, UK). Images were obtained using a Zeiss Pascal confocal microscope. Voxx 
rendering software (Clendenon et al., 2002) was used for 3-D reconstruction.  
Lac-Z expression in whole mounts of TS muscles from heterozygous tenascin-C null mutant 
mice was detected by X-gal staining solution, with a solution containing 2 mM MgCl
2
, 5 mM 
K
3
Fe(CN)
6
, 5 mM 0.02% NP-40, and 1 mg/ml Xgal (5-bromo-4-chloro-3indolyl-D-galactoside; 
Sigma). Image post-processing was carried out using Adobe Photoshop, and/or Image J software, 
in compliance with Journal of Cell Science image manipulation policy.  
Sources and dilutions of species-specific antibodies  
Antibodies were obtained from the following suppliers and used at indicated dilutions: rabbit 
2166 (Peter Brophy, University of Edinburgh; 1:200); mouse anti-desmin (DAKO; 1:200); rat 
IgG2k F4/80 (Serotec; 1:50); mouse IgG1 anti-GFAP (Boehringer; 1:100); rat IgG anti-Laminin 
(a2 chain) (Alexis; 1:200); rabbit anti-M-Cadherin (Anton Wernig, University of Bonn; 1:50); 
rabbit anti-N-CAM (Elisabeth Bock, University of Copenhagen; 1:100); mouse IgG1 anti-Nestin 
(Susan Hockfield, Yale University; 1:200); mouse anti-neurofilament (165 kDa) (DHSB; 1:200); 
rabbit anti-S100 (DAKO; 1:200); mouse IgG1 anti-S100 (SA1259) (Affinity; 1:200); mouse 
anti-SV2 (SAPU; 1:200); mouse IgG1 anti-Thy 1.1 (Serotec; 1:100); rat IgG2b anti-CD34 (BD 
PharMingen; 1:50); mouse IgG1 anti-prolyl-4-hydroxylase (Acris Medicorp; 1:100); rat IgG 
anti-tenascin (Abcam; 1:200); rabbit HM-24 (Jonathan Cohen, Harvard Medical School; 1:200). 
Electron microscopy  
Isolated mouse TS muscle was fixed in 4% paraformaldehyde and 2.5% glutaraldehyde in ice-
cold 0.1M phosphate buffer for 4 hours, then post-fixed in 1% osmium tetroxide for 45 minutes, 
J Cell Sci. 2008 Dec 1;121(Pt 23):3901‐11. doi: 10.1242/jcs.031047. Epub 2008 Nov 11. 
 
dehydrated in ethanol and propylene oxide and embedded in Durcupan resin. Three hundred 
ultrathin (75-100 nm) serial sections were cut from the endplate region, collected on formvar-
coated grids (Agar Scientific, UK), stained with uranyl acetate and lead citrate then viewed in a 
Philips CM12 transmission electron microscope. Electron photomicrograph negatives were 
scanned at 1000 dpi. A few sections were lost during preparation (<20 out of 300), so these were 
replaced in the final image stack by a duplicate of a neighbouring serial section. Digitised 
micrographs were then transferred to a Unix workstation (Sun Microsystems) and a custom 
programme (Reconstruct) was used to generate 3D-voxel images. The programme “MAPaint” 
was used to reconstruct 3D volumes of the nerve terminal, skeletal muscle fibre, terminal 
Schwann cell and 2166 cells. Both Reconstruct and MAPaint were written and developed in the 
MRC Human Genetics Unit, Edinburgh http://genex.hgu.mrc.ac.uk). Different cell types were 
identified in each individual 2D image before manually delineating their borders. The 3D 
volumes were saved to independent files, calibrated and surface rendered using Imaris software 
(Bitplane; Zurich, Switzerland).  
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ABBREVIATIONS (163 words)  
2166 – Polyclonal antibody recognising kranocytes and other cell types AChR – Acetylcholine 
receptor BrdU – bromodeoxyuridine BoNT/A – botulinum toxin Type A C57Bl/6 – Standard 
laboratory mouse line CD34 – Stem cell marker CTB – Cholera Toxin B-subunit DAPI -4',6-
diamidino-2-phenylindole DG2 – antiganglioside antibody DL – deep lumbrical muscles EDL – 
extensor digitorum longus muscle F4/80 – macrogphage marker FDB – flexor digitorum brevis 
muscle GAP-43 – growth associated protein of molecular weight 43kDa GGFII – glial growth 
factor 2; neuregulin GFAP – glial fibrillary acidic protein GFP – Green Fluorescent Protein HM-
24 – Neuregulin antiserum ICC – Interstitial Cells of Cajal KLH -keyhole limpet hemocyanin Lac-
Z – β-galactosidase NCAM – neural cell adhesion molecule NMJ -Neuromuscular Junctions tSC 
– Terminal Schwann Cells R6/2 – Huntington’s Disease model: transgenic mouse line rPH – rat 
prolyl-4-hydroxylase S100 – Ammonium-sulfate soluble Schwann cell antigen TRITC – 
tetramethylrhodamine isothiocyanate TRITC-α-BTX – TRITC conjugated with α-bungarotoxin TS 
– triangularis sterni muscle Tspan-2 – tetraspanin protein 2 WB – Western blot X-gal -β-
galactosidase stain  
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Figure 1  
Immunostaining of mouse triangularis sterni muscles with 2166 antibody reveals 
capping cells at NMJ’s. A: low power confocal projection showing numerous 2166-
positive interstitial cells and a prominent sub-population in the vicinity of NMJ’s. B: 
higher power confocal projection images of NMJ-capping cells (green), juxtaposed with 
motor endplates counterstained with TRITC-α-BTX (red). C: Triple-stained NMJ with 
axon stained with neurofilament antibodies (red), NMJ-capping cell (green) and motor 
endplate AChR stained with Alexafluor647-α-BTX (blue). D, E: other interstitial and 
endothelial cells with positive 2166 immunostaining were scattered at low density 
throughout the muscles. F: quantification of density of NMJ-capping cells at motor 
endplates. All endplates showed at least one and most were associated with only one 
NMJ-capping cell; no NMJ was associated with more than three of these cells. Scale 
bars: A, 100 µm; B, 20 µm (applies also to C and D).  
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Figure 2  
NMJ-capping cells are not Schwann cells but express collagensynthesising 
enzyme and neuregulin. A: Confocal projection images of a triangularis sterni endplate 
in an S100-eGFP transgenic, showing endogenous fluorescence in terminal Schwann 
cells (green) overlying endplate ACh receptors (blue). The right panel of the pair shows 
superimposition of 2166 immunostaining (red). B: Immunostaining for the collagen-
synthesising enzyme prolyl-4hydroxylase (rPH) of an NMJ-capping cell in rat triangularis 
sterni muscle. C: Immunostaining of a NMJ-capping cell in mouse triangularis sterni 
muscle using HM-24 antibody, which recognizes GGFII/neuregulin. Scale bar: 50 µm  
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Figure 3            
NMJ-capping cells are CD34 antibody and CTB positive and reside outside the 
synaptic basal lamina. A,B: Confocal projections of an NMJ-capping cell in a mouse 
triangularis sterni muscle immunostained with 2166 (green) and CD34 (red) antibodies 
and with endplate AChR counterstained (blue). Lower panels in A show green and red 
channels separately; Panels 1 and 2 in B show orthogonal projections at the optical cuts 
indicated in the uppermost panel. C: Transverse section of a mouse TS muscle 
immunostained with 2166 antibody (green spots), laminin antibody (red) and endplate 
AChR (blue). The immunostained processes of the NMJ-capping cells clearly lie outside 
the basal lamina. D: Fluorescent conjugates of CTB also stain cells similar in form and 
location to NMJ-capping cells. Right panel shows the red channel indicating endplate 
AChR only. Scale bars: A, 50 µm (applies also to C); D, 50 µm.  
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Figure 4  
NMJ-capping cells almost completely cover motor endplates.  
Electron micrographs and 3D surface-rendered reconstructions of serially-sectioned 
electron micrographs showing the relationship between two putative NMJ-capping cells, 
motor nerve terminal, terminal Schwann cell and skeletal muscle fibre at a 
neuromuscular junction from mouse TS muscle. A,B. Sections 84 and 75 respectively 
from a 300-section series through a single NMJ. The soma and thin cytoplasmic 
processes of both NMJ-capping cells at this NMJ can be seen above the terminal 
Schwann cell and nerve terminal, lying outside the basal lamina. Each of the main cell 
types have been outlined on these electron micrographs (motor nerve terminal -green; 
muscle fibre -brown, terminal Schwann cell -yellow; 2166 cells -magenta and lilac). C: 
Surface rendering of reconstructed serial electron micrographs from the NMJ shown in 
A and B revealed two NMJ-capping cells (magenta and lilac) overlying a single terminal 
Schwann cell (yellow) and a motor nerve terminal (green) synapsing with a skeletal 
muscle fibre (brown). a: superior view of the nerve terminal and skeletal muscle fibre; b: 
nerve terminal only; c: nerve terminal and terminal Schwann cell; d: nerve terminal, 
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Schwann cell and two NMJ-capping cells; e: nerve terminal and two NMJ-capping cells; 
f: two NMJ-capping cells; g/h: the two NMJ-capping cells shown in isolation; i: 
orthogonal view of the reconstructed NMJ-capping cells. Animations of the volume-
rendering of these two cells are presented in Supplementary Movies 6 & 7. The NMJ-
capping cells cover approximately 60% of the nerve terminal at this NMJ. In contrast to 
the terminal Schwann cell, the veil-like processes of both NMJ-capping cells extend 
beyond the immediate boundaries of the endplate. D. Transmission electron micrograph 
through a neuromuscular junction in the rat diaphragm. The motor nerve terminal and 
terminal Schwann cell are covered by a slender process from a putative NMJ-capping 
cell (arrows; a high resolution image is reproduced in Supplementary Figure 3). Scale 
bar: 2.5 µm.  
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Figure 5  
NMJ-capping cells become restricted to the endplate zone postnatally but spread 
following denervation in adults. A-C: 2166 immunostaining (green) is diffuse at birth 
but becomes progressively concentrated near NMJ’s over the following 1-2 weeks. D-F: 
Denervation in adults triggers nestin reactivity and sprouting in terminal Schwann cells 
within 3 days but no discernible sprouting or nestin immunoreactivity is seen 1 day after 
axotomy. In contrast, extensive spreading of 2166 immunostaining occurs within 1 day 
of axotomy (See also Supplementary Figure 4). At 3 days, some of the Schwann cell 
sprouts were associated with 2166-positive links between motor endplates (arrowhead; 
see also Supplementary Figure 5). G: Immunostaining following injection of a BrdU 
pulse shows BrdU positive staining (red) of nuclei (blue) in both junctional and non-
junctional 2166-positive cells (green), suggesting that NMJ-capping cells both divide 
and spread from endplates following axotomy. Arrowheads indicate BrdU positive 
nuclei. Scale bar: A-C, 100 µm; D-G, 50 µm (applies also to D, E and F).  
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Figure 6  
NMJ-capping cells also spread in paralysed and atrophic muscles. A,B: Profusion 
of 2166-immunoreactivity (green) is seen within one day of injection of a locally-
paralysing dose of botulinum toxin type-A but terminal Schwann-cell reactivity and 
sprouting, assessed by nestin immunostaining (red), is not observed until at least 6 
days of paralysis in TS muscles. C,D: Similar profusion and spread of NMJ-capping 
cells is observed in constitutively atrophic muscles of 15-week old R6/2 transgenic mice. 
Littermate controls show normal, endplatelocalised staining and distribution of NMJ-
capping cells. Scale bar: 50 µm  
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Figure 7  
Reactive NMJ-capping cells are associated with tenascin-C expression but do not 
require tenascin-C in order to localize, react or spread from NMJ’s.  
A-C: Tenascin-C immunoreactivity (red) spread from the endplate region from 36 days 
after axotomy (left panels) and these tenascin-C rich regions coincide with the 
distribution of NMJ-capping cells (green, right panels; AChR counterstained blue). D,E: 
Selective X-Gal staining of intramuscular nerve and motor endplates in heterozygous 
tenascin-C null mutant mice with lac-Z substitution, 5 days after axotomy. The area 
shown in E corresponds to the area bounded by the dotted outline in D. Unoperated 
muscles were X-Gal negative (not shown). F,G: NMJ-capping cells are also localized to 
NMJ in homozygous tenascin-C null mutant mice and these cells spread from endplates 
3 days after axotomy, as in wild-type mice. Scale bars: F, 50 µm (applies also to A, B, C 
and E); G, 50 µm  
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Figure 8  
NMJ-capping cells are integral, plastic cellular components of the NMJ.  
A: Cartoon depicting the relationship between four main cell types proposed to 
constitute the mammalian NMJ: muscle fibre, motor nerve terminal, terminal 
(perisynaptic) Schwann Cell and NMJ-capping cells, named here as “kranocytes” (see 
Discussion). B: Stages in kranocyte reactivity to denervation, paralysis or muscle 
atrophy that could indicate a permissive function for these cells in terminal Schwann cell 
and axonal sprouting. Kranocyte sprouting is the first reaction, followed by terminal 
Schwann cell sprouting, then axonal sprouting.  
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LEGENDS TO SUPPLEMENTARY FIGURES AND MOVIES  
Supplementary Figure 1  
NMJ-capping cells are Thy-1 negative but co-localise after denervation with activated 
terminal Schwann cells. Panels showing combined (left) and separated (middle and left) 
colour channels of preparations immunostained with 2166 antibody and either Thy 1.1 
(A) or S100 (B). A. Co-immunostaining of mouse triangularis sterni muscle with 2166 
antibody (green) and Thy-1.1 antibody (red) show no co-localisation. However, Thy-1 
immunopositivity was observed in some of the other perijunctional fibroblasts and 
intramuscular capillaries. Acetylcholine receptors were counterstained with fluorescent 
bungarotoxin (pseudocoloured blue). B. Co-immunostaining of rat 4th deep lumbrical 
muscle with 2166 antibody (green) and S100 antibody (red) 6 days after section of the 
tibial nerve. Sprouts between muscle fibres made by NMJ-capping cells and terminal 
Schwann cells are clearly coincident and associated, but the antibodies are evidently 
not colocalised in the same cells.  
Supplementary Figure 2  
Supplementary to Fig 3B/C, 2166 immunostaining of transverse muscle sections shows 
thin NMJ-capping cell processes lying outside the synaptic basal lamina, as indicated by 
co-staining for laminin (red) and Alexa647-α-BTX (blue). Calibration 20 µm  
Supplementary Figure 3  
High resolution image of the NMJ shown in Figure 4D. Note the thin basal lamina 
around most of the putative NMJ-capping cell and its processes above the NMJ, and 
the presence of rough ER in the cytoplasm. Key: MF – muscle fibre; NT-nerve terminal; 
tSC – terminal Schwann Cell; K-Kranocyte; BL – basal lamina. Calibration 2 µm.  
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Supplementary Figure 4  
Co-staining of TS muscles in unoperated muscles (A,B) and 1 day after axotomy (C,D) 
with 2166 antibody (green), DAPI (blue; nuclei) and TRITC-α-BTX (AChR). These 
images show evidence of a rapid increase in the number of 2166-positive cells per NMJ 
following denervation. Calibration 30 µm (A,B); 20 µm (C,D).  
Supplementary Figure 5  
Co-staining of a 3-day denervated TS muscle with 2166 antibody (green), nestin (red) 
and Alexa647-α-BTX (blue). Note the association of a cell processes from an NMJ 
capping cell and a nestin-positive tSC sprout. This figure shows separation of the RGB 
channels for the same image as Figure 5E. Calibration 40 µm.  
Supplementary Movie 1  
Z-series of triple-stained NMJ shown in flat projection in Fig 2B rPH (red) /2166 
(green)/AChR (blue)  
Supplementary Movie 2  
Animated rotating projection of z-series for triple-stained NMJ shown in Supplementary 
Movie 1 and in flat projection in Fig 2B. rPH (red) /2166 (green)/AChR (blue)  
Supplementary Movie 3  
Z-series of endplate AChR stained with TRITC-α-BTX, shown in projection and with 
volume rendering in Fig 3D  
Supplementary Movie 4  
Z-series of NMJ-capping cells stained with CTB, shown in projection and with volume 
rendering in Fig 3D  
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Supplementary Movie 5  
Animated rotating projection of Z-series of NMJ-capping cells stained with CTB, shown 
in Supplementary Movie 4 and in projection with volume rendering in Fig 3D  
Supplementary Movie 6  
Volume rendered animation of one of the reconstructed NMJ-capping cells shown in Fig 
4A-C.  
Supplementary Movie 7  
Volume rendered animation of the other reconstructed NMJ-capping cell shown in Fig 
4A-C.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 1  
Panel of cellular and molecular markers used to screen for NMJ-capping cell epitopes. 
Positive staining was obtained with CD34, rPH, HM-24 and CTB. Other markers of 
Schwann cells, macrophages, fibroblasts and other satellite cells did not stain NMJ-
capping cells.  
  
Antibody/Marker  Cell Type or Antigen  2166 Cells  
   
S100  Schwann Cells  - 
GFAP  Reactive Schwann Cells  - 
Nestin  Reactive Schwann Cells  - 
M-Cadherin  Satellite Cells  - 
NCAM  Satellite Cells  - 
Desmin  Satellite Cells  - 
Thy-1  Fibroblasts/Neurons  - 
F4/80  Macrophages  - 
CD34  Stem Cells  +  
rPH  Fibroblasts  +  
HM-24  GGFII-related molecules  +  
CTB  GM1 Ganglioside  +  
